Spinal Bupivacaine/Morphine in Laparoscopic Gastro-intestinal Surgery

NCT02284282 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2018-08-08

No results posted yet for this study

Summary

The objective of this study is to determine if a single spinal shot of morphine can decrease post-operative opioid-use, and thereby decrease opioid side-effects and lead to a quicker recovery after surgery.

Conditions

  • Spinal Bupivacaine/Morphine in Laparoscopic Surgery

Interventions

DRUG

Spinal injection bupivacaine/morphine

Spinal injection bupivacaine/morphine in laparoscopic surgery

DRUG

subcutaneum injection lidocaine

placebo injection

Sponsors & Collaborators

  • Maasstad Hospital

    lead OTHER

Principal Investigators

  • AartJan JW Teunissen, MD · Maasstad Hospital

  • Mark V Koning, MD · Maasstad Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02284282 on ClinicalTrials.gov